To determine the potential molecular mechanisms by which NEDD4 promotes breast tumor growth and progression, we determined the expression of NEDD4 along with PTEN, IGF-1R, and p-Akt by IHC using a TMA that consisted of 148 samples of early-stage primary invasive breast cancer. The gene discussed is NEDD4; the disease is invasive breast carcinoma.